A Retrospective Study of the Impact of 21-Gene Recurrence Score Assay on Treatment Choice in Node Positive Micrometastatic Breast Cancer.

Autor: Frazier, Thomas G.1 tgf@tgfsurgery.com, Fox, Kevin R.2 Kevin.Fox@uphs.upenn.edu, Smith, J. Stanley3 jsmith9@hmc.psu.edu, Laronga, Christine4 Christine.Laronga@moffitt.org, McSwain, Anita5 amcswain@mfa.gwu.edu, Paul, Devchand6 devchand.paul@usoncology.com, Schultz, Michael7 michaelschultz@umm.edu, Stilwill, Joseph8 Joseph.stilwill@hcahealthcare.com, Teal, Christine5 cteal@mfa.gwu.edu, Weisberg, Tracey9 weisbt@mccm.org, Vacchino, Judith F.10 JVacchino@genomichealth.com, Sing, Amy P.10 asing@genomichealth.com, Cherepanov, Dasha11 dasha@pharllc.com, Hsiao, Wendy12 wendy.hsiao@usc.edu, Chang, Eunice11 echang@pharllc.com, Broder, Michael S.11 mbroder@pharllc.com
Zdroj: Pharmaceuticals (14248247). 2015, Vol. 8 Issue 1, p107-122. 16p.
Databáze: Academic Search Ultimate